Galectin Therapeutics Inc

MORGAN STANLEY GALT

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

279,288

Value ($000)

1,162

Weight

0.0%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,162	0.0%	279,288	12/31/2025
2025 Q3	11/14/2025	967	0.0%	228,335	9/30/2025
2025 Q2	8/14/2025	440	0.0%	208,623	6/30/2025
2025 Q1	5/15/2025	299	0.0%	245,092	3/31/2025
2024 Q4	5/15/2025	374	0.0%	290,084	12/31/2024
2024 Q3	5/14/2025	677	0.0%	246,080	9/30/2024
2024 Q2	5/14/2025	514	0.0%	227,217	6/30/2024
2024 Q1	5/15/2024	441	0.0%	184,691	3/31/2024
2023 Q4	2/13/2024	307	0.0%	185,147	12/31/2023
2023 Q3	11/15/2023	355	0.0%	184,759	9/30/2023
2023 Q2	8/14/2023	267	0.0%	185,084	6/30/2023
2023 Q1	5/15/2023	395	0.0%	188,329	3/31/2023
2022 Q4	2/14/2023	44	0.0%	38,765	12/31/2022
2022 Q3	11/14/2022	61	0.0%	37,547	9/30/2022
2022 Q2	10/27/2022	77	0.0%	58,856	6/30/2022
2022 Q1	10/27/2022	102	0.0%	63,509	3/31/2022
2021 Q4	2/14/2022	194	0.0%	93,303	12/31/2021
2021 Q3	11/15/2021	195	0.0%	49,968	9/30/2021
2021 Q2	8/23/2021	131	0.0%	40,810	6/30/2021
2021 Q1	5/17/2021	57	0.0%	26,360	3/31/2021
2020 Q4	2/16/2021	121	0.0%	53,662	12/31/2020
2020 Q3	11/13/2020	85	0.0%	31,579	9/30/2020
2020 Q2	8/14/2020	199	0.0%	65,192	6/30/2020
2020 Q1	5/26/2020	109	0.0%	55,511	3/31/2020
2019 Q4	2/14/2020	468	0.0%	163,561	12/31/2019
2014 Q1	5/13/2014	1,407	0.0%	91,946	3/31/2014
2013 Q4	2/13/2014	143	0.0%	17,680	12/31/2013